gabapentin has been researched along with Itching in 74 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Gabapentin and intravenous patient-controlled analgesia (PCA) can reduce postoperative pain scores, postoperative opioid use, and time to completing physical therapy compared to PCA alone after posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS)." | 9.41 | Gabapentin and intrathecal morphine combination therapy results in decreased oral narcotic use and more consistent pain scores after posterior spinal fusion for adolescent idiopathic scoliosis. ( Caird, MS; Hong, RA; Leis, A; Li, Y; Robbins, C; Swallow, J, 2021) |
| "Gabapentin and doxepin are well-known treatments of uremic pruritus in hemodialysis patients but no head-to-head studies were conducted to date." | 9.34 | Comparison of gabapentin and doxepin in the management of uremic pruritus: A randomized crossover clinical trial. ( Ammoury, A; Bachour, J; Haber, R; Habr, L; Joubran, N; Khoury, F; Maacaron, T; Salloum, A, 2020) |
| "To compare the effect of gabapentin (GBP) and hydroxyzine (HYDZ) in treating pruritus in patients on dialysis." | 9.34 | Comparison of gabapentin and hydroxyzine in the treatment of pruritus in patients on dialysis. ( Ghorghani, M; Hoseininia, S; Mohammadi Kebar, S; Sharghi, A, 2020) |
| " Treatment with 6% topical gabapentin resulted in significantly decreased mean pruritus scores at 1 week (mean score 2." | 9.34 | A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus. ( Aquino, TMO; Luchangco, KAC; Sanchez, EV; Verallo-Rowell, VM, 2020) |
| " dexchlorpheniramine in reducing uremic pruritus." | 9.27 | Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial. ( Abbade, LP; Gobo-Oliveira, M; Miot, HA; Ogata, MS; Pigari, VG; Ponce, D, 2018) |
| "Gabapentin relieved itching in 47 patients (66%)." | 9.16 | Uraemic pruritus: relief of itching by gabapentin and pregabalin. ( Baharani, J; Dasgupta, I; Rayner, H; Smith, S; Suresh, V, 2012) |
| "To compare the efficacy and side effects of gabapentin and desloratadine in patients with dialysis pruritus." | 9.16 | Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin. ( Barrón, B; Lauxmann, JE; Marquez, D; Martinatto, C; Novoa, PA; Orías, M; Peixoto, AJ; Ramonda, C; Romero, CA; Vukelic, VL, 2012) |
| "Gabapentin is an effective agent in treating uremic pruritus." | 9.14 | Gabapentin and uremic pruritus in hemodialysis patients. ( Eskandari, D; Ganji, MR; Khashayar, P; Meysamie, AP; Razeghi, E; Togha, M, 2009) |
| "The incidence of pruritus was significantly more frequent in the placebo group compared with the gabapentin group (77." | 9.13 | Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. ( Chang, FL; Ho, ST; Lee, CH; Sheen, MJ; Tsung, YC, 2008) |
| "Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception." | 9.12 | Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006) |
| "Our study shows that gabapentin is safe and effective for treating uraemic pruritus in haemodialysis patients." | 9.11 | Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. ( Celiker, H; Gunal, AI; Gunal, SY; Kirciman, E; Ozalp, G; Yoldas, TK, 2004) |
| "Gabapentin has an antipruritus effect, which its efficacy in reducing pruritus induced by intrathecal morphine has not been well documented." | 8.88 | Single dose of gabapentin for prophylaxis intrathecal morphine-induced pruritus in orthopedic surgery: a randomized controlled trial. ( Chiravanich, W; Kovitwanawong, N; Oofuvong, M, 2012) |
| "To evaluate the efficacy and safety of gabapentin and oral antidepressants in patients with chronic pruritus in daily clinical practice." | 8.31 | Gabapentin and oral antidepressants for chronic pruritus: a prospective cohort study evaluating efficacy and side effects in daily dermatological practice. ( Kamsteeg, M; Kouwenhoven, TA; van de Kerkhof, PCM, 2023) |
| "A retrospective review of charts and pharmacy records of gabapentin and pregabalin dispensed to control pruritus and/or pain was conducted for burn survivors up to 20 years of age." | 7.88 | Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review. ( Amin, A; Kaul, I; Meyer, WJ; Rosenberg, L; Rosenberg, M, 2018) |
| "To determine the safety and effectiveness of gabapentin for pruritus or RLS in conservatively managed patients (n = 34) with CKD and ESKD." | 7.81 | Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease. ( Brennan, F; Brown, MA; Cheikh Hassan, HI; Collett, G; Josland, EA, 2015) |
| "Compared with that before treatment, the itching degree of patients with light, moderate, and severe itching in placebo group was not relieved after treatment; the itching degree of patients with moderate or severe itching in cetirizine group was alleviated after treatment, but not in patients with light itching; itching degree of all patients in gabapentin group was significantly relieved after treatment." | 7.81 | [Clinical effects of gabapentin on the treatment of pruritus of scar resulting from deep partial-thickness burn]. ( Bing, Z; Qiang, W; Wei, L; Zheng, L, 2015) |
| "Itching was induced via neonatal capsaicin treatment in Sprague-Dawley rats (itching rats), and scratching behavior of the control, itching, and gabapentin (GBP)-treated itching rats was compared." | 7.81 | Investigation of the pruritus-induced functional activity in the rat brain using manganese-enhanced MRI. ( Jeong, KY; Kang, JH, 2015) |
| "To evaluate the efficacy of gabapentin for the treatment of uremic pruritus (UP)." | 7.74 | Role of gabapentin in the treatment of uremic pruritus. ( Gommer, J; Scates, AC; Vila, T, 2008) |
| "We describe the use of gabapentin for the treatment of itching in wound healing in 35 children." | 7.72 | Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. ( Mendham, JE, 2004) |
| "Pruritus is a symptom that adversely affects the quality of life of patients with epidermolysis bullosa (EB)." | 7.11 | Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double-blind, split-site, randomized controlled trial. ( Ahramiyanpour, N; Hosseini, SA; Parvizi, MM; Saki, N; Shafie'ei, M; Vahedi, S, 2022) |
| "Gabapentin is a promising and a well-tolerated treatment option for patients with UP." | 6.82 | Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature. ( Abdelkhalik, Z; Alkot, R; Eldesouky, F; Farag, F; Nofal, A; Nofal, E, 2016) |
| "Pruritus is common in dialysis patients." | 6.77 | Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. ( Atalay, H; Biyik, Z; Covic, A; Gaipov, A; Goldsmith, D; Guney, F; Kanbay, M; Solak, Y; Turk, S, 2012) |
| "Gabapentin is an antiepileptic drug which has been successfully used to manage neuropathic pain, and is reporting to be successful in management of all forms of itch." | 6.76 | A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. ( Ahuja, RB; Gupta, G; Gupta, R; Shrivastava, P, 2011) |
| "Gabapentin is an effective drug in the management of neuropathic pain." | 6.73 | Gabapentin: a promising drug for the treatment of uremic pruritus. ( Harandi, AA; Khanbabapour, S; Mohseni, M; Naini, AE; Seirafiyan, S; Shahidi, S, 2007) |
| "Uremic pruritus is one of the most prevalent and bothersome dermatologic symptoms in patients with end-stage renal disease." | 6.66 | Gabapentin for uremic pruritus: a systematic review of randomized controlled trials. ( Castillo, RL; Dofitas, BL; Eusebio-Alpapara, KMV, 2020) |
| "Chronic pruritus is a distressing symptom that is often refractory to treatment." | 6.53 | Gabapentin and pregabalin for the treatment of chronic pruritus. ( Kwatra, SG; Matsuda, KM; Schonfeld, AR; Sharma, D, 2016) |
| "Gabapentin and intravenous patient-controlled analgesia (PCA) can reduce postoperative pain scores, postoperative opioid use, and time to completing physical therapy compared to PCA alone after posterior spinal fusion (PSF) for adolescent idiopathic scoliosis (AIS)." | 5.41 | Gabapentin and intrathecal morphine combination therapy results in decreased oral narcotic use and more consistent pain scores after posterior spinal fusion for adolescent idiopathic scoliosis. ( Caird, MS; Hong, RA; Leis, A; Li, Y; Robbins, C; Swallow, J, 2021) |
| "Brachioradial pruritus is a characteristic clinical condition with a deep intense itching, tingling or burning sensation localized to the dorsolateral part of the upper extremities." | 5.38 | [Brachioradial pruritus effectively treated with gabapentin]. ( Bygum, A; Uldall Pallesen, KA, 2012) |
| " Treatment with 6% topical gabapentin resulted in significantly decreased mean pruritus scores at 1 week (mean score 2." | 5.34 | A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus. ( Aquino, TMO; Luchangco, KAC; Sanchez, EV; Verallo-Rowell, VM, 2020) |
| "To compare the effect of gabapentin (GBP) and hydroxyzine (HYDZ) in treating pruritus in patients on dialysis." | 5.34 | Comparison of gabapentin and hydroxyzine in the treatment of pruritus in patients on dialysis. ( Ghorghani, M; Hoseininia, S; Mohammadi Kebar, S; Sharghi, A, 2020) |
| "Gabapentin and doxepin are well-known treatments of uremic pruritus in hemodialysis patients but no head-to-head studies were conducted to date." | 5.34 | Comparison of gabapentin and doxepin in the management of uremic pruritus: A randomized crossover clinical trial. ( Ammoury, A; Bachour, J; Haber, R; Habr, L; Joubran, N; Khoury, F; Maacaron, T; Salloum, A, 2020) |
| " dexchlorpheniramine in reducing uremic pruritus." | 5.27 | Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial. ( Abbade, LP; Gobo-Oliveira, M; Miot, HA; Ogata, MS; Pigari, VG; Ponce, D, 2018) |
| "To compare the efficacy and side effects of gabapentin and desloratadine in patients with dialysis pruritus." | 5.16 | Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin. ( Barrón, B; Lauxmann, JE; Marquez, D; Martinatto, C; Novoa, PA; Orías, M; Peixoto, AJ; Ramonda, C; Romero, CA; Vukelic, VL, 2012) |
| "Gabapentin relieved itching in 47 patients (66%)." | 5.16 | Uraemic pruritus: relief of itching by gabapentin and pregabalin. ( Baharani, J; Dasgupta, I; Rayner, H; Smith, S; Suresh, V, 2012) |
| "Gabapentin is an effective agent in treating uremic pruritus." | 5.14 | Gabapentin and uremic pruritus in hemodialysis patients. ( Eskandari, D; Ganji, MR; Khashayar, P; Meysamie, AP; Razeghi, E; Togha, M, 2009) |
| "The incidence of pruritus was significantly more frequent in the placebo group compared with the gabapentin group (77." | 5.13 | Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery. ( Chang, FL; Ho, ST; Lee, CH; Sheen, MJ; Tsung, YC, 2008) |
| "Pruritus is defined as the second order of nociception, the first being pain; thus, there is a rationale to study gabapentin, a drug that increases the threshold to experience nociception." | 5.12 | Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial. ( Bergasa, NV; Engler, D; Ginsburg, IH; McGee, M, 2006) |
| "Our study shows that gabapentin is safe and effective for treating uraemic pruritus in haemodialysis patients." | 5.11 | Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial. ( Celiker, H; Gunal, AI; Gunal, SY; Kirciman, E; Ozalp, G; Yoldas, TK, 2004) |
| " In the meantime, gabapentin appears to be the most evidence-based widely available uremic pruritus treatment, as long as care is taken with dosing and monitoring of side-effects." | 5.05 | Recent advances in the treatment of uremic pruritus. ( Collister, D; Rigatto, C; Trachtenberg, AJ, 2020) |
| "Despite the acknowledged importance of uremic pruritus to patients, with the exception of gabapentin, the current evidence for treatments is weak." | 4.95 | Treatment of Uremic Pruritus: A Systematic Review. ( Askin, N; Bohm, C; Komenda, P; Lerner, B; Rigatto, C; Shaw, J; Simonsen, E; Tangri, N, 2017) |
| " The complications of vomiting, nausea, dizziness and pruritus were also compiled to assess the safety of gabapentin and pregabalin." | 4.93 | The efficacy of preoperative administration of gabapentin/pregabalin in improving pain after total hip arthroplasty: a meta-analysis. ( Ding, W; Mao, Y; Wu, L, 2016) |
| "Gabapentin has an antipruritus effect, which its efficacy in reducing pruritus induced by intrathecal morphine has not been well documented." | 4.88 | Single dose of gabapentin for prophylaxis intrathecal morphine-induced pruritus in orthopedic surgery: a randomized controlled trial. ( Chiravanich, W; Kovitwanawong, N; Oofuvong, M, 2012) |
| "To evaluate the efficacy and safety of gabapentin and oral antidepressants in patients with chronic pruritus in daily clinical practice." | 4.31 | Gabapentin and oral antidepressants for chronic pruritus: a prospective cohort study evaluating efficacy and side effects in daily dermatological practice. ( Kamsteeg, M; Kouwenhoven, TA; van de Kerkhof, PCM, 2023) |
| "We studied 23 patients with severe pruritus scoring at least 5 on the visual analogue scale (VAS) and refractory to antihistamine and gabapentin administration." | 3.88 | Effect of cold pack therapy for management of burn scar pruritus: A pilot study. ( Cho, YS; Joo, SY; Kim, JB; Seo, CH, 2018) |
| "A retrospective review of charts and pharmacy records of gabapentin and pregabalin dispensed to control pruritus and/or pain was conducted for burn survivors up to 20 years of age." | 3.88 | Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review. ( Amin, A; Kaul, I; Meyer, WJ; Rosenberg, L; Rosenberg, M, 2018) |
| "Itching was induced via neonatal capsaicin treatment in Sprague-Dawley rats (itching rats), and scratching behavior of the control, itching, and gabapentin (GBP)-treated itching rats was compared." | 3.81 | Investigation of the pruritus-induced functional activity in the rat brain using manganese-enhanced MRI. ( Jeong, KY; Kang, JH, 2015) |
| "Compared with that before treatment, the itching degree of patients with light, moderate, and severe itching in placebo group was not relieved after treatment; the itching degree of patients with moderate or severe itching in cetirizine group was alleviated after treatment, but not in patients with light itching; itching degree of all patients in gabapentin group was significantly relieved after treatment." | 3.81 | [Clinical effects of gabapentin on the treatment of pruritus of scar resulting from deep partial-thickness burn]. ( Bing, Z; Qiang, W; Wei, L; Zheng, L, 2015) |
| "To determine the safety and effectiveness of gabapentin for pruritus or RLS in conservatively managed patients (n = 34) with CKD and ESKD." | 3.81 | Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease. ( Brennan, F; Brown, MA; Cheikh Hassan, HI; Collett, G; Josland, EA, 2015) |
| " Gabapentin has been successfully used to treat cutaneous pain and pruritus in a variety of conditions." | 3.77 | A case of post-herpetic itch resolved with gabapentin. ( Jagdeo, J; Kroshinsky, D, 2011) |
| "To evaluate the efficacy of gabapentin for the treatment of uremic pruritus (UP)." | 3.74 | Role of gabapentin in the treatment of uremic pruritus. ( Gommer, J; Scates, AC; Vila, T, 2008) |
| "We describe the use of gabapentin for the treatment of itching in wound healing in 35 children." | 3.72 | Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study. ( Mendham, JE, 2004) |
| "Pruritus is a symptom that adversely affects the quality of life of patients with epidermolysis bullosa (EB)." | 3.11 | Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double-blind, split-site, randomized controlled trial. ( Ahramiyanpour, N; Hosseini, SA; Parvizi, MM; Saki, N; Shafie'ei, M; Vahedi, S, 2022) |
| "Brachioradial pruritis is a rare dysesthesia syndrome that is known to negatively impact quality of life." | 2.82 | Treatment modalities in brachioradial pruritis: a systematic review. ( Amerson, E; Zakaria, A, 2022) |
| "Gabapentin is a promising and a well-tolerated treatment option for patients with UP." | 2.82 | Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature. ( Abdelkhalik, Z; Alkot, R; Eldesouky, F; Farag, F; Nofal, A; Nofal, E, 2016) |
| "Pruritus is common in dialysis patients." | 2.77 | Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study. ( Atalay, H; Biyik, Z; Covic, A; Gaipov, A; Goldsmith, D; Guney, F; Kanbay, M; Solak, Y; Turk, S, 2012) |
| "Gabapentin is an antiepileptic drug which has been successfully used to manage neuropathic pain, and is reporting to be successful in management of all forms of itch." | 2.76 | A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus. ( Ahuja, RB; Gupta, G; Gupta, R; Shrivastava, P, 2011) |
| "Gabapentin is an effective drug in the management of neuropathic pain." | 2.73 | Gabapentin: a promising drug for the treatment of uremic pruritus. ( Harandi, AA; Khanbabapour, S; Mohseni, M; Naini, AE; Seirafiyan, S; Shahidi, S, 2007) |
| "Post-burn pruritus is the pruritus that occurs after burn during the rehabilitation and healing process of burn wounds." | 2.66 | Post-Burn Pruritus. ( Chung, BY; Jung, MJ; Kang, SY; Kim, HB; Kim, HO; Kwak, IS; Park, CW, 2020) |
| "Uremic pruritus is one of the most prevalent and bothersome dermatologic symptoms in patients with end-stage renal disease." | 2.66 | Gabapentin for uremic pruritus: a systematic review of randomized controlled trials. ( Castillo, RL; Dofitas, BL; Eusebio-Alpapara, KMV, 2020) |
| "Dermatologists play a key role in the treatment of CTCL-pruritus by guiding the patient in the importance of preserving the integrity of the skin barrier." | 2.58 | Pruritus in Cutaneous T-Cell Lymphoma and Its Management. ( Guitart, J; Martinez-Escala, ME; Serrano, L; Zhou, XA, 2018) |
| "Chronic pruritus is a distressing symptom that is often refractory to treatment." | 2.53 | Gabapentin and pregabalin for the treatment of chronic pruritus. ( Kwatra, SG; Matsuda, KM; Schonfeld, AR; Sharma, D, 2016) |
| "The risk ratios (95% CI) for postoperative nausea, vomiting, pruritus and sedation with gabapentin were: 0." | 2.52 | A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain. ( Doleman, B; Faleiro, RJ; Heinink, TP; Lund, JN; Read, DJ; Williams, JP, 2015) |
| "Post burn pruritus is a well recognised symptom in almost all burn patients." | 2.48 | Post burn pruritus--a review of current treatment options. ( Gupta, AK; Lamba, S; Paul, MK; Prabha, R; Rao, AL; Zachariah, JR, 2012) |
| " As only a minority of respondents felt comfortable prescribing these drugs, more education on effective and safe dosing is needed." | 1.51 | Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands. ( Kamsteeg, M; Kouwenhoven, TA; van de Kerkhof, PCM, 2019) |
| "Gabapentin was used by 45% as first-, second-, or third-line treatment." | 1.46 | International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis. ( Bieber, BA; Ecder, T; Graham-Brown, M; Hasegawa, T; Kleophas, W; Larkina, M; Pisoni, RL; Rayner, HC; Robinson, BM; Tentori, F; van der Veer, SN; Wang, M, 2017) |
| "Treatment with gabapentin led to a prompt reduction of the symptoms." | 1.39 | Episodic itch in a case of spinal glioma. ( Dihné, M; Lerche, H; Wolking, S, 2013) |
| "Brachioradial pruritus is a characteristic clinical condition with a deep intense itching, tingling or burning sensation localized to the dorsolateral part of the upper extremities." | 1.38 | [Brachioradial pruritus effectively treated with gabapentin]. ( Bygum, A; Uldall Pallesen, KA, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.35) | 18.2507 |
| 2000's | 17 (22.97) | 29.6817 |
| 2010's | 42 (56.76) | 24.3611 |
| 2020's | 14 (18.92) | 2.80 |
| Authors | Studies |
|---|---|
| Solinski, HJ | 1 |
| Dranchak, P | 1 |
| Oliphant, E | 1 |
| Gu, X | 1 |
| Earnest, TW | 1 |
| Braisted, J | 1 |
| Inglese, J | 1 |
| Hoon, MA | 1 |
| Li, Y | 1 |
| Swallow, J | 1 |
| Robbins, C | 1 |
| Caird, MS | 1 |
| Leis, A | 1 |
| Hong, RA | 1 |
| Gutierrez, RA | 1 |
| Berger, TG | 1 |
| Shah, V | 1 |
| Agnihothri, R | 1 |
| Demir-Deviren, S | 1 |
| Fassett, MS | 1 |
| Saki, N | 1 |
| Vahedi, S | 1 |
| Parvizi, MM | 1 |
| Shafie'ei, M | 1 |
| Hosseini, SA | 1 |
| Ahramiyanpour, N | 1 |
| Zakaria, A | 1 |
| Amerson, E | 1 |
| Kouwenhoven, TA | 2 |
| van de Kerkhof, PCM | 2 |
| Kamsteeg, M | 2 |
| Rossi, GM | 1 |
| Corradini, M | 1 |
| Blanco, V | 1 |
| Mattei, S | 1 |
| Fiaccadori, E | 1 |
| Vaglio, A | 4 |
| Manenti, L | 4 |
| Uysal Tan, F | 1 |
| Koc, RS | 1 |
| Erkek Ozturk Durmaz, E | 1 |
| Tuncez Akyurek, F | 1 |
| Eusebio-Alpapara, KMV | 1 |
| Castillo, RL | 1 |
| Dofitas, BL | 1 |
| Krajewski, P | 1 |
| Szepietowski, JC | 2 |
| Mohammadi Kebar, S | 1 |
| Sharghi, A | 1 |
| Ghorghani, M | 1 |
| Hoseininia, S | 1 |
| Aquino, TMO | 1 |
| Luchangco, KAC | 1 |
| Sanchez, EV | 1 |
| Verallo-Rowell, VM | 1 |
| Chung, BY | 1 |
| Kim, HB | 1 |
| Jung, MJ | 1 |
| Kang, SY | 1 |
| Kwak, IS | 1 |
| Park, CW | 1 |
| Kim, HO | 1 |
| Trachtenberg, AJ | 1 |
| Collister, D | 1 |
| Rigatto, C | 2 |
| Haber, R | 1 |
| Bachour, J | 1 |
| Salloum, A | 1 |
| Maacaron, T | 1 |
| Khoury, F | 1 |
| Habr, L | 1 |
| Ammoury, A | 1 |
| Joubran, N | 1 |
| Russell, M | 1 |
| Zare, M | 1 |
| Lee, HG | 1 |
| Grossman, SK | 1 |
| Valdes-Rodriguez, R | 1 |
| Berenato, F | 1 |
| Korbutov, J | 1 |
| Chan, YH | 1 |
| Lavery, MJ | 1 |
| Yosipovitch, G | 2 |
| Simonsen, E | 1 |
| Komenda, P | 1 |
| Lerner, B | 1 |
| Askin, N | 1 |
| Bohm, C | 1 |
| Shaw, J | 1 |
| Tangri, N | 1 |
| Kaul, I | 1 |
| Amin, A | 1 |
| Rosenberg, M | 1 |
| Rosenberg, L | 1 |
| Meyer, WJ | 1 |
| Rayner, HC | 1 |
| Larkina, M | 1 |
| Wang, M | 1 |
| Graham-Brown, M | 1 |
| van der Veer, SN | 1 |
| Ecder, T | 1 |
| Hasegawa, T | 1 |
| Kleophas, W | 1 |
| Bieber, BA | 1 |
| Tentori, F | 1 |
| Robinson, BM | 1 |
| Pisoni, RL | 1 |
| Joo, SY | 1 |
| Kim, JB | 1 |
| Cho, YS | 2 |
| Seo, CH | 1 |
| Akiyama, T | 1 |
| Andoh, T | 1 |
| Ohtsuka, E | 1 |
| Nojima, H | 1 |
| Ouchi, H | 1 |
| Takahata, H | 1 |
| Kuraishi, Y | 1 |
| Pereira, MP | 1 |
| Basta, S | 1 |
| Moore, J | 1 |
| Ständer, S | 2 |
| Serrano, L | 1 |
| Martinez-Escala, ME | 1 |
| Zhou, XA | 1 |
| Guitart, J | 1 |
| Reszke, R | 1 |
| Gobo-Oliveira, M | 1 |
| Pigari, VG | 1 |
| Ogata, MS | 1 |
| Miot, HA | 1 |
| Ponce, D | 1 |
| Abbade, LP | 1 |
| Rayner, H | 1 |
| Baharani, J | 1 |
| Smith, S | 1 |
| Suresh, V | 1 |
| Dasgupta, I | 1 |
| Bernhard, JD | 3 |
| Wolking, S | 1 |
| Lerche, H | 1 |
| Dihné, M | 1 |
| Mettang, T | 2 |
| Kremer, AE | 1 |
| Yong, AS | 1 |
| Lee, KY | 1 |
| Cheikh Hassan, HI | 1 |
| Brennan, F | 1 |
| Collett, G | 1 |
| Josland, EA | 1 |
| Brown, MA | 1 |
| Jeong, KY | 1 |
| Kang, JH | 1 |
| Doleman, B | 1 |
| Heinink, TP | 1 |
| Read, DJ | 1 |
| Faleiro, RJ | 1 |
| Lund, JN | 1 |
| Williams, JP | 1 |
| Zheng, L | 1 |
| Bing, Z | 1 |
| Wei, L | 1 |
| Qiang, W | 1 |
| Nofal, E | 1 |
| Farag, F | 1 |
| Nofal, A | 1 |
| Eldesouky, F | 1 |
| Alkot, R | 1 |
| Abdelkhalik, Z | 1 |
| Zhai, L | 1 |
| Song, Z | 1 |
| Liu, K | 1 |
| Matsuda, KM | 1 |
| Sharma, D | 1 |
| Schonfeld, AR | 1 |
| Kwatra, SG | 1 |
| Ward, RE | 1 |
| Veerula, VL | 1 |
| Ezra, N | 1 |
| Travers, JB | 1 |
| Mousdicas, N | 1 |
| Mao, Y | 1 |
| Wu, L | 1 |
| Ding, W | 1 |
| Pongcharoen, P | 1 |
| Fleischer, AB | 1 |
| Şavk, E | 1 |
| Hoeijmakers, JG | 1 |
| Faber, CG | 1 |
| Miedema, CJ | 1 |
| Merkies, IS | 1 |
| Vles, JS | 1 |
| Razeghi, E | 1 |
| Eskandari, D | 1 |
| Ganji, MR | 1 |
| Meysamie, AP | 1 |
| Togha, M | 1 |
| Khashayar, P | 1 |
| Clarke, H | 1 |
| Pereira, S | 1 |
| Kennedy, D | 1 |
| Andrion, J | 1 |
| Mitsakakis, N | 1 |
| Gollish, J | 1 |
| Katz, J | 1 |
| Kay, J | 1 |
| Yilmaz, S | 1 |
| Ceyhan, AM | 1 |
| Baysal Akkaya, V | 1 |
| Bang, SR | 1 |
| Yu, SK | 1 |
| Kim, TH | 1 |
| Nakamizo, S | 1 |
| Miyachi, Y | 1 |
| Kabashima, K | 1 |
| Ahuja, RB | 1 |
| Gupta, R | 1 |
| Gupta, G | 1 |
| Shrivastava, P | 1 |
| Jagdeo, J | 1 |
| Kroshinsky, D | 1 |
| Zachariah, JR | 1 |
| Rao, AL | 1 |
| Prabha, R | 1 |
| Gupta, AK | 1 |
| Paul, MK | 1 |
| Lamba, S | 1 |
| Chiravanich, W | 1 |
| Oofuvong, M | 1 |
| Kovitwanawong, N | 1 |
| Anand, S | 1 |
| Uldall Pallesen, KA | 1 |
| Bygum, A | 1 |
| Marquez, D | 1 |
| Ramonda, C | 1 |
| Lauxmann, JE | 1 |
| Romero, CA | 1 |
| Vukelic, VL | 1 |
| Martinatto, C | 1 |
| Barrón, B | 1 |
| Novoa, PA | 1 |
| Peixoto, AJ | 1 |
| Orías, M | 1 |
| Solak, Y | 1 |
| Biyik, Z | 1 |
| Atalay, H | 1 |
| Gaipov, A | 1 |
| Guney, F | 1 |
| Turk, S | 1 |
| Covic, A | 1 |
| Goldsmith, D | 1 |
| Kanbay, M | 1 |
| Winhoven, SM | 1 |
| Coulson, IH | 1 |
| Bottomley, WW | 1 |
| Mendham, JE | 1 |
| Gunal, AI | 1 |
| Ozalp, G | 1 |
| Yoldas, TK | 1 |
| Gunal, SY | 1 |
| Kirciman, E | 1 |
| Celiker, H | 1 |
| Schürmeyer-Horst, F | 1 |
| Fischbach, R | 1 |
| Nabavi, D | 1 |
| Metze, D | 1 |
| Yesudian, PD | 1 |
| Wilson, NJ | 1 |
| Demierre, MF | 1 |
| Taverna, J | 1 |
| Bergasa, NV | 1 |
| McGee, M | 1 |
| Ginsburg, IH | 1 |
| Engler, D | 1 |
| Kosmadakis, GC | 1 |
| Zerefos, N | 1 |
| Naini, AE | 1 |
| Harandi, AA | 1 |
| Khanbabapour, S | 1 |
| Shahidi, S | 1 |
| Seirafiyan, S | 1 |
| Mohseni, M | 1 |
| Loosemore, MP | 1 |
| Bordeaux, JS | 1 |
| Borgatti, PP | 1 |
| Vila, T | 1 |
| Gommer, J | 1 |
| Scates, AC | 1 |
| Sheen, MJ | 1 |
| Ho, ST | 1 |
| Lee, CH | 1 |
| Tsung, YC | 1 |
| Chang, FL | 1 |
| Bueller, HA | 1 |
| Dubroff, LM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of the Effects of Liquid Vaseline and Olive Oil on Itching and Scarring in Scald Burns[NCT06104540] | 24 participants (Anticipated) | Interventional | 2023-11-01 | Not yet recruiting | |||
| The Treatment Effect of Chinese Medicine Formula on Uremic Pruritus[NCT04650750] | Early Phase 1 | 60 participants (Anticipated) | Interventional | 2020-12-01 | Not yet recruiting | ||
| Prospective Randomized Study Evaluating the Efficacy of the Spherical Absorptive Carbon AST-120 in Hemodialysis Patients With Uremic Pruritus..[NCT04639674] | Phase 4 | 100 participants (Actual) | Interventional | 2020-07-02 | Completed | ||
| A pRospective, Case-controlled Evaluation of oLIceridine for Moderate or sEVEre Pain in Patients With Acute Burn Injuries. (RELIEVE)[NCT05465226] | Phase 4 | 31 participants (Actual) | Interventional | 2023-04-01 | Completed | ||
| Effectiveness of Sertraline in Alleviating Uremic Pruritis in Hemodialysis Patients[NCT05341843] | Phase 2 | 60 participants (Actual) | Interventional | 2022-05-01 | Completed | ||
| A Double-Blind Randomized Placebo-Controlled Clinical Trial of Preoperative Gabapentin Prior to Vaginal Apical Suspension Prolapse Procedures[NCT05658887] | Phase 4 | 110 participants (Anticipated) | Interventional | 2023-01-01 | Enrolling by invitation | ||
| Opioid-Free Shoulder Arthroplasty[NCT03540030] | Phase 4 | 86 participants (Actual) | Interventional | 2016-09-30 | Completed | ||
| "Preoperative Gabapentin and Its Effects on Postoperative Analgesia in Patients Undergoing Cosmetic Breast Surgery"[NCT05997355] | 100 participants (Anticipated) | Interventional | 2023-09-01 | Not yet recruiting | |||
| Phenomics and Genomics of Clinically Relevant Chronic Postsurgical Pain: A Multicenter Prospective Study[NCT04798573] | 10,000 participants (Anticipated) | Observational | 2012-08-03 | Active, not recruiting | |||
| Pre-Emptive Analgesia in Ano-Rectal Surgery[NCT02402543] | 90 participants (Actual) | Interventional | 2014-06-30 | Completed | |||
| Aprepitant vs. Desloratadine in Non-small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors Related Pruritus: A Prospective, Randomized Control, Double-blinded, Phase II Clinical Trial[NCT02646020] | Phase 2 | 138 participants (Actual) | Interventional | 2015-12-31 | Completed | ||
| Study of Gabapentin for the Pruritus of Cholestasis[NCT00058890] | Phase 3 | 15 participants (Actual) | Interventional | 2000-11-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
American Shoulder and Elbow Surgeons (ASES) Shoulder Score for pain and function. Range 0-100. Low score = worse shoulder condition. Function, disability, and pain subscores (all ranges 0-50), and are summed for total ASES score. (NCT03540030)
Timeframe: 2 Weeks
| Intervention | units on a scale (Median) |
|---|---|
| Observational | 54.3 |
| Non-Opioid Intervention | 54.2 |
Morphine milli-equivalents In-hospital post-operative. Continuous scale of MME, no defined better/worse. Measured as number and dose of medications taken. For example, if the patient received an opioid, the drug and dose was recorded and converted to MME. A time frame of when to assess opioid use in-hospital post-operative was not used but was a continuous monitor for rescue opioid from in-hospital post-operative through discharge. (NCT03540030)
Timeframe: In-hospital Stay
| Intervention | Morphine milli-equivalents (Median) |
|---|---|
| Observational | 45.0 |
| Non-Opioid Intervention | 19.0 |
Pain at patient discharge or 24-hours, whichever comes first - measured on a 0 (no pain) -10 (worst possible pain) numeric rating scale (NRS). A score of 0(no pain) is preferable to 10(worst possible pain) (NCT03540030)
Timeframe: 24 hours
| Intervention | score on a scale (Median) |
|---|---|
| Observational | 3.0 |
| Non-Opioid Intervention | 2.0 |
Simple Shoulder Test (SST) activity score. Range 0-12. 0 = worse activity score. (NCT03540030)
Timeframe: 2 Months
| Intervention | score on a scale (Median) |
|---|---|
| Observational | 6 |
| Non-Opioid Intervention | 6 |
Simple Shoulder Test (SST) activity score. Range 0-12. 0 = worse activity score. (NCT03540030)
Timeframe: 2 Weeks
| Intervention | score on a scale (Median) |
|---|---|
| Observational | 2.0 |
| Non-Opioid Intervention | 2.0 |
post-operative pain: measured on a 0 (no pain) -10 (worst) numeric rating scale (NRS) at 6hrs, 12hrs, 2 weeks, and 2 months. A score of 0(no pain) is preferable to 10(worst possible pain) (NCT03540030)
Timeframe: 6hrs, 12hrs, 2weeks, 2 months
| Intervention | score on a scale (Median) | |||
|---|---|---|---|---|
| 6 Hrs | 12 hrs | 2 weeks | 2 months | |
| Non-Opioid Intervention | 0.0 | 0 | 0.82 | 0 |
| Observational | 2 | 4 | 1.3 | 0.7 |
rate of constipation (NCT03540030)
Timeframe: 2 Months
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 4 | 27 | 4 |
| Observational | 7 | 21 | 2 |
rate of constipation (NCT03540030)
Timeframe: 2 Weeks
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 13 | 22 | 0 |
| Observational | 19 | 9 | 2 |
rate of falls (NCT03540030)
Timeframe: 2 Months
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 4 | 27 | 4 |
| Observational | 4 | 24 | 2 |
rate of falls (NCT03540030)
Timeframe: 2 Weeks
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 5 | 30 | 0 |
| Observational | 1 | 27 | 2 |
rate of nausea (NCT03540030)
Timeframe: 2 Months
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 1 | 30 | 0 |
| Observational | 0 | 28 | 2 |
rate of nausea (NCT03540030)
Timeframe: 2 Weeks
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 1 | 34 | 0 |
| Observational | 5 | 23 | 2 |
Satisfaction with overall pain using Numeric Pain Rating (NRS) scale. yes, no. No being better than yes. (NCT03540030)
Timeframe: 2 Months
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 29 | 2 | 4 |
| Observational | 23 | 5 | 2 |
Satisfaction with overall pain using Numeric Pain Rating (NRS) scale. yes, no. No being better than yes. (NCT03540030)
Timeframe: 2 Weeks
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| Yes | No | Unknown | |
| Non-Opioid Intervention | 34 | 1 | 0 |
| Observational | 27 | 1 | 2 |
quality of life using VR-12 subscores. Physical Health (PCS) subscore and Mental Health (MCS) subscore, not summed. Range reported in weighted units. Physical Health subscore: 1 point increase in PCS is associated with 6% lower total health care expenditures, 5% lower pharmacy expenditures, 9% lower rate of hospital inpatient visits, 4% lower rate of medical provider visits, 5% lower rate of hospital outpatient visits. Mental Health sub score a 1 point increase in MCS is associated with 7% lower total health care expenditures, 4% lower pharmacy expenditures, 15% lower rate of hospital inpatient visits, and 4% lower rate of medical provider visits. Both PCS/MCS are score 0-100 with 100 indicating the highest level of health. (NCT03540030)
Timeframe: 2 Months
| Intervention | score on a scale (Median) | |
|---|---|---|
| PCS | MCS | |
| Non-Opioid Intervention | 40.3 | 60.8 |
| Observational | 38.4 | 58.7 |
quality of life using VR-12 subscores. Physical Health (PCS) subscore and Mental Health (MCS) subscore, not summed. Range reported in weighted units. Physical Health subscore: 1 point increase in PCS is associated with 6% lower total health care expenditures, 5% lower pharmacy expenditures, 9% lower rate of hospital inpatient visits, 4% lower rate of medical provider visits, 5% lower rate of hospital outpatient visits. Mental Health sub score a 1 point increase in MCS is associated with 7% lower total health care expenditures, 4% lower pharmacy expenditures, 15% lower rate of hospital inpatient visits, and 4% lower rate of medical provider visits. Both PCS/MCS are score 0-100 with 100 indicating the highest level of health. (NCT03540030)
Timeframe: 2 Weeks
| Intervention | score on a scale (Median) | |
|---|---|---|
| PCS | MCS | |
| Non-Opioid Intervention | 35.0 | 59.1 |
| Observational | 36.7 | 56.3 |
21 reviews available for gabapentin and Itching
| Article | Year |
|---|---|
Treatment modalities in brachioradial pruritis: a systematic review.
Topics: Antidepressive Agents, Tricyclic; Capsaicin; Gabapentin; Humans; Pregabalin; Pruritus; Quality of Li | 2022 |
Gabapentin for uremic pruritus: a systematic review of randomized controlled trials.
Topics: Dizziness; Gabapentin; Humans; Incidence; Kidney Failure, Chronic; Pruritus; Randomized Controlled T | 2020 |
Notalgia paresthetica treated with low dose of gabapentin: Case report and literature review.
Topics: Gabapentin; Humans; Peripheral Nervous System Diseases; Pruritus; Skin Diseases | 2020 |
Post-Burn Pruritus.
Topics: Animals; Antipsychotic Agents; Burns; Gabapentin; Histamine Antagonists; Humans; Inflammation; Kerat | 2020 |
Recent advances in the treatment of uremic pruritus.
Topics: Gabapentin; Humans; Piperidines; Pruritus; Renal Dialysis; Renal Insufficiency, Chronic | 2020 |
How to assess and relieve that perplexing rashless itch.
Topics: Antipruritics; Chronic Disease; Diagnosis, Differential; Evidence-Based Medicine; Gabapentin; Humans | 2020 |
Treatment of Uremic Pruritus: A Systematic Review.
Topics: Administration, Cutaneous; Amines; Analgesics; Anti-Asthmatic Agents; Antipruritics; Capsaicin; Crom | 2017 |
Treatment of Uremic Pruritus: A Systematic Review.
Topics: Administration, Cutaneous; Amines; Analgesics; Anti-Asthmatic Agents; Antipruritics; Capsaicin; Crom | 2017 |
Treatment of Uremic Pruritus: A Systematic Review.
Topics: Administration, Cutaneous; Amines; Analgesics; Anti-Asthmatic Agents; Antipruritics; Capsaicin; Crom | 2017 |
Treatment of Uremic Pruritus: A Systematic Review.
Topics: Administration, Cutaneous; Amines; Analgesics; Anti-Asthmatic Agents; Antipruritics; Capsaicin; Crom | 2017 |
Pruritus in Cutaneous T-Cell Lymphoma and Its Management.
Topics: Adrenal Cortex Hormones; Amines; Antidepressive Agents, Tricyclic; Antipruritics; Cyclohexanecarboxy | 2018 |
End-Stage Renal Disease Chronic Itch and Its Management.
Topics: Amines; Analgesics, Opioid; Anticonvulsants; Antipruritics; Chronic Disease; Cyclohexanecarboxylic A | 2018 |
Clinical practice. Chronic pruritus.
Topics: Amines; Antidepressive Agents, Tricyclic; Behavior Therapy; Chronic Disease; Cyclohexanecarboxylic A | 2013 |
Uremic pruritus.
Topics: Acupuncture Therapy; Amines; Anti-Inflammatory Agents; Calcium Channel Blockers; Cyclohexanecarboxyl | 2015 |
A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain.
Topics: Amines; Analgesics; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Drug Administration Schedule; D | 2015 |
A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain.
Topics: Amines; Analgesics; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Drug Administration Schedule; D | 2015 |
A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain.
Topics: Amines; Analgesics; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Drug Administration Schedule; D | 2015 |
A systematic review and meta-regression analysis of prophylactic gabapentin for postoperative pain.
Topics: Amines; Analgesics; Analgesics, Opioid; Cyclohexanecarboxylic Acids; Drug Administration Schedule; D | 2015 |
The Effect of Gabapentin on Acute Postoperative Pain in Patients Undergoing Total Knee Arthroplasty: A Meta-Analysis.
Topics: Amines; Analgesics; Analgesics, Opioid; Arthroplasty, Replacement, Knee; Cyclohexanecarboxylic Acids | 2016 |
Gabapentin and pregabalin for the treatment of chronic pruritus.
Topics: Amines; Anti-Anxiety Agents; Chronic Disease; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma | 2016 |
The efficacy of preoperative administration of gabapentin/pregabalin in improving pain after total hip arthroplasty: a meta-analysis.
Topics: Amines; Analgesics; Arthroplasty, Replacement, Hip; Cyclohexanecarboxylic Acids; Dizziness; Gabapent | 2016 |
Itch Management: Systemic Agents.
Topics: Amines; Analgesics; Analgesics, Opioid; Anion Exchange Resins; Antidepressive Agents; Aprepitant; Ch | 2016 |
Neurologic Itch Management.
Topics: Acupuncture Therapy; Amines; Anesthetics, Local; Anticonvulsants; Antipruritics; Botulinum Toxins, T | 2016 |
Uremic Itch Management.
Topics: Acupuncture Therapy; Amines; Analgesics, Opioid; Anticonvulsants; Calcineurin Inhibitors; Cyclohexan | 2016 |
Post burn pruritus--a review of current treatment options.
Topics: Amines; Analgesics; Burns; Cyclohexanecarboxylic Acids; Emollients; Gabapentin; gamma-Aminobutyric A | 2012 |
Single dose of gabapentin for prophylaxis intrathecal morphine-induced pruritus in orthopedic surgery: a randomized controlled trial.
Topics: Adolescent; Adult; Aged; Amines; Analgesics, Opioid; Anesthesia, Spinal; Antipruritics; Cyclohexanec | 2012 |
Gabapentin for pruritus in palliative care.
Topics: Amines; Analgesics, Opioid; Burns; Cholestasis; Cyclohexanecarboxylic Acids; Dermatologic Agents; Ga | 2013 |
19 trials available for gabapentin and Itching
| Article | Year |
|---|---|
Gabapentin and intrathecal morphine combination therapy results in decreased oral narcotic use and more consistent pain scores after posterior spinal fusion for adolescent idiopathic scoliosis.
Topics: Adolescent; Analgesia, Patient-Controlled; Analgesics, Opioid; Gabapentin; Humans; Kyphosis; Morphin | 2021 |
Topical gabapentin 10% in the treatment of epidermolysis bullosa pruritus: A pilot, double-blind, split-site, randomized controlled trial.
Topics: Adolescent; Adult; Child; Double-Blind Method; Epidermolysis Bullosa; Female; Gabapentin; Humans; Ma | 2022 |
Randomized trial of two after-dialysis gabapentin regimens for severe uremic pruritus in hemodialysis patients.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Double-Blind Method; Female; Gabapentin; Humans; Male; M | 2019 |
Comparison of gabapentin and hydroxyzine in the treatment of pruritus in patients on dialysis.
Topics: Administration, Oral; Adult; Anti-Anxiety Agents; Antipruritics; Case-Control Studies; Cross-Over St | 2020 |
A randomized controlled study of 6% gabapentin topical formulation for chronic kidney disease-associated pruritus.
Topics: Double-Blind Method; Gabapentin; Humans; Pruritus; Renal Dialysis; Renal Insufficiency, Chronic; Tre | 2020 |
Comparison of gabapentin and doxepin in the management of uremic pruritus: A randomized crossover clinical trial.
Topics: Double-Blind Method; Doxepin; Gabapentin; Histamine Antagonists; Humans; Pruritus; Quality of Life; | 2020 |
Gabapentin versus dexchlorpheniramine as treatment for uremic pruritus: a randomised controlled trial.
Topics: Aged; Chlorpheniramine; Double-Blind Method; Excitatory Amino Acid Antagonists; Female; Gabapentin; | 2018 |
Uraemic pruritus: relief of itching by gabapentin and pregabalin.
Topics: Adult; Aged; Aged, 80 and over; Amines; Analgesics; Comorbidity; Cyclohexanecarboxylic Acids; Dose-R | 2012 |
Gabapentin: A promising therapy for uremic pruritus in hemodialysis patients: A randomized-controlled trial and review of literature.
Topics: Adult; Aged; Amines; Cyclohexanecarboxylic Acids; Double-Blind Method; Excitatory Amino Acid Antagon | 2016 |
Gabapentin and uremic pruritus in hemodialysis patients.
Topics: Adult; Aged; Amines; Anticonvulsants; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Gaba | 2009 |
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla | 2009 |
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla | 2009 |
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla | 2009 |
Adding gabapentin to a multimodal regimen does not reduce acute pain, opioid consumption or chronic pain after total hip arthroplasty.
Topics: Acute Disease; Aged; Amines; Analgesics; Analgesics, Opioid; Anesthesia, Spinal; Arthroplasty, Repla | 2009 |
Can gabapentin help reduce postoperative pain in arthroscopic rotator cuff repair? A prospective, randomized, double-blind study.
Topics: Aged; Amines; Analgesia, Patient-Controlled; Analgesics, Non-Narcotic; Anti-Anxiety Agents; Arthrosc | 2010 |
A comparative analysis of cetirizine, gabapentin and their combination in the relief of post-burn pruritus.
Topics: Adolescent; Adult; Aged; Amines; Analgesics; Burns; Cetirizine; Child; Cyclohexanecarboxylic Acids; | 2011 |
Uremic pruritus in hemodialysis patients: treatment with desloratidine versus gabapentin.
Topics: Amines; Cross-Over Studies; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Histam | 2012 |
Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.
Topics: Adult; Aged; Amines; Analgesics; Antipruritics; Chi-Square Distribution; Cross-Over Studies; Cyclohe | 2012 |
Gabapentin therapy for pruritus in haemodialysis patients: a randomized, placebo-controlled, double-blind trial.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Humans | 2004 |
Gabapentin in patients with the pruritus of cholestasis: a double-blind, randomized, placebo-controlled trial.
Topics: Adult; Amines; Analgesics; Cholestasis; Chronic Disease; Cyclohexanecarboxylic Acids; Double-Blind M | 2006 |
Gabapentin: a promising drug for the treatment of uremic pruritus.
Topics: Adult; Aged; Aged, 80 and over; Amines; Cyclohexanecarboxylic Acids; Double-Blind Method; Female; Ga | 2007 |
Preoperative gabapentin prevents intrathecal morphine-induced pruritus after orthopedic surgery.
Topics: Adult; Amines; Anesthesia, Spinal; Anesthetics, Local; Antipruritics; Bupivacaine; Cyclohexanecarbox | 2008 |
34 other studies available for gabapentin and Itching
| Article | Year |
|---|---|
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
Topics: Animals; Behavior, Animal; Cell-Free System; Dermatitis, Contact; Disease Models, Animal; Ganglia, S | 2019 |
Evaluation of Gabapentin and Transforaminal Corticosteroid Injections for Brachioradial Pruritus.
Topics: Adrenal Cortex Hormones; Cervical Vertebrae; Gabapentin; Humans; Pruritus | 2022 |
Gabapentin and oral antidepressants for chronic pruritus: a prospective cohort study evaluating efficacy and side effects in daily dermatological practice.
Topics: Adult; Amines; Antidepressive Agents; Cohort Studies; Cyclohexanecarboxylic Acids; Drug-Related Side | 2023 |
Gabapentin treatment in notalgia paresthetica: a preliminary report.
Topics: Adult; Back; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Gabapentin; Hum | 2020 |
Topical ketamine-amitriptyline-lidocaine for chronic pruritus: A retrospective study assessing efficacy and tolerability.
Topics: Aged; Amines; Amitriptyline; Analgesics; Chronic Disease; Cyclohexanecarboxylic Acids; Drug Therapy, | 2017 |
Use of gabapentin and pregabalin for pruritus and neuropathic pain associated with major burn injury: A retrospective chart review.
Topics: Adolescent; Analgesics; Burns; Child; Child, Preschool; Female; Gabapentin; Humans; Infant; Male; Ne | 2018 |
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female | 2017 |
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female | 2017 |
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female | 2017 |
International Comparisons of Prevalence, Awareness, and Treatment of Pruritus in People on Hemodialysis.
Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Chronic Disease; Cyclohexanecarboxylic Acids; Female | 2017 |
Effect of cold pack therapy for management of burn scar pruritus: A pilot study.
Topics: Adult; Burns; Cicatrix; Cryotherapy; Excitatory Amino Acid Antagonists; Female; Gabapentin; Histamin | 2018 |
Peripheral gabapentin regulates mosquito allergy-induced itch in mice.
Topics: Amines; Animals; Antipruritics; Calcium Channels; Culicidae; Cyclohexanecarboxylic Acids; Gabapentin | 2018 |
Prurigo nodularis: a physician survey to evaluate current perceptions of its classification, clinical experience and unmet need.
Topics: Adult; Aged; Aged, 80 and over; Analgesics; Chronic Disease; Gabapentin; Histamine Antagonists; Huma | 2018 |
Use of Systemic Treatment in Patients with Chronic Pruritus: A Survey of Dermatologists in the Netherlands.
Topics: Adult; Antidepressive Agents; Antipruritics; Chronic Disease; Dermatologists; Drug Prescriptions; Fe | 2019 |
Episodic itch in a case of spinal glioma.
Topics: Aged; Amines; Analgesics; Cyclohexanecarboxylic Acids; Evoked Potentials, Somatosensory; Female; Gab | 2013 |
Uremic pruritus is improved by gabapentin.
Topics: Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric A | 2014 |
Efficacy and safety of gabapentin for uremic pruritus and restless legs syndrome in conservatively managed patients with chronic kidney disease.
Topics: Aged; Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma- | 2015 |
Investigation of the pruritus-induced functional activity in the rat brain using manganese-enhanced MRI.
Topics: Amines; Animals; Animals, Newborn; Brain; Brain Mapping; Capsaicin; Contrast Media; Cyclohexanecarbo | 2015 |
[Clinical effects of gabapentin on the treatment of pruritus of scar resulting from deep partial-thickness burn].
Topics: Amines; Analgesics; Ascorbic Acid; Burns; Cetirizine; Cicatrix; Cyclohexanecarboxylic Acids; Gabapen | 2015 |
Multilevel symmetric neuropathic pruritus (MSNP) presenting as recalcitrant "generalized" pruritus.
Topics: Age Distribution; Aged; Amines; Chronic Disease; Cohort Studies; Cyclohexanecarboxylic Acids; Diseas | 2016 |
Small Fiber Neuropathy in Children: Two Case Reports Illustrating the Importance of Recognition.
Topics: Adolescent; Amines; Analgesics; Biopsy; Cyclohexanecarboxylic Acids; Duloxetine Hydrochloride; Eryth | 2016 |
Brachioradial pruritus successfully treated with gabapentin.
Topics: Amines; Cyclohexanecarboxylic Acids; Dermatologic Agents; Forearm; Gabapentin; gamma-Aminobutyric Ac | 2010 |
Treatment of neuropathic itch possibly due to trigeminal trophic syndrome with 0.1% topical tacrolimus and gabapentin.
Topics: Administration, Cutaneous; Amines; Analgesics; Antipruritics; Cyclohexanecarboxylic Acids; Drug Ther | 2010 |
A case of post-herpetic itch resolved with gabapentin.
Topics: Adult; Amines; Cyclohexanecarboxylic Acids; Female; Gabapentin; gamma-Aminobutyric Acid; Herpes Zost | 2011 |
[Brachioradial pruritus effectively treated with gabapentin].
Topics: Amines; Antipruritics; Arm; Brachial Plexus Neuropathies; Cervical Vertebrae; Cyclohexanecarboxylic | 2012 |
Brachioradial pruritus: response to treatment with gabapentin.
Topics: Acetates; Aged; Amines; Arm; Cyclohexanecarboxylic Acids; Dermatologic Agents; Female; Gabapentin; g | 2004 |
Gabapentin for the treatment of itching produced by burns and wound healing in children: a pilot study.
Topics: Adolescent; Amines; Antipruritics; Burns; Child; Child Behavior Disorders; Child, Preschool; Cyclohe | 2004 |
[Brachioradial pruritus: a rare, localized, neuropathic form of itching].
Topics: Amines; Anticonvulsants; Cervical Vertebrae; Cyclohexanecarboxylic Acids; Female; Forearm; Gabapenti | 2006 |
Gabapentin for uraemic pruritus.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Prurit | 2005 |
Efficacy of gabapentin in the management of pruritus of unknown origin.
Topics: Aged; Aged, 80 and over; Amines; Antipruritics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Amino | 2005 |
Mirtazapine and gabapentin for reducing pruritus in cutaneous T-cell lymphoma.
Topics: Amines; Anticonvulsants; Antidepressive Agents, Tricyclic; Cyclohexanecarboxylic Acids; Gabapentin; | 2006 |
Uremic pruritus.
Topics: Amines; Analgesics, Non-Narcotic; Analgesics, Opioid; Capsaicin; Cyclohexanecarboxylic Acids; Gabape | 2006 |
Gabapentin use in chronic uraemic itch is in line with emerging pathogenetic hypothesis.
Topics: Amines; Chronic Disease; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; P | 2007 |
Gabapentin treatment for notalgia paresthetica, a common isolated peripheral sensory neuropathy.
Topics: Aged, 80 and over; Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric A | 2007 |
Gabapentin as a therapeutic option in uremic pruritus.
Topics: Amines; Analgesics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Prurit | 2008 |
Role of gabapentin in the treatment of uremic pruritus.
Topics: Amines; Antipruritics; Cyclohexanecarboxylic Acids; Gabapentin; gamma-Aminobutyric Acid; Humans; Kid | 2008 |
Gabapentin treatment for brachioradial pruritus.
Topics: Acetates; Administration, Oral; Amines; Arm; Cyclohexanecarboxylic Acids; Drug Administration Schedu | 1999 |